Literature DB >> 12237253

Protective effect of relaxin in cardiac anaphylaxis: involvement of the nitric oxide pathway.

E Masini1, G Zagli, J F Ndisang, M Solazzo, P F Mannaioni, D Bani.   

Abstract

1 Relaxin (RLX) is a multifunctional hormone best known for its role in pregnancy and parturition, that has been also shown to influence coronary perfusion and mast cell activation through the generation of endogenous nitric oxide (NO). In this study we report on the effects of RLX on the biochemical and mechanical changes of ex vivo perfused hearts isolated from ovalbumin-sensitized guinea-pigs induced by challenge with the specific antigen. The possible involvement of NO in the RLX action has been also investigated. 2 A 30-min perfusion with RLX (30 ng ml(-1)) before ovalbumin challenge fully abated the positive chronotropic and inotropic effects evoked by anaphylactic reaction to the antigen. RLX also blunted the short-term coronary constriction following to antigen challenge. Conversely, perfusion with chemically inactivated RLX had no effect. 3 The release of histamine in the perfusate and the accumulation of calcium in heart tissue induced by antigen challenge were significantly decreased by RLX, while the amounts of nitrites in the perfusate were significantly increased, as were NO synthase activity and expression and cGMP levels in heart tissue. 4 These findings indicate that RLX has a protective effect in cardiac anaphylaxis which involves an up-regulation of the NO biosynthetic pathway.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12237253      PMCID: PMC1573501          DOI: 10.1038/sj.bjp.0704879

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  35 in total

1.  Relaxin favors the development of activated human T cells into Th1-like effectors.

Authors:  M P Piccinni; D Bani; L Beloni; C Manuelli; C Mavilia; F Vocioni; M Bigazzi; T B Sacchi; S Romagnani; E Maggi
Journal:  Eur J Immunol       Date:  1999-07       Impact factor: 5.532

2.  Relaxin counteracts myocardial damage induced by ischemia-reperfusion in isolated guinea pig hearts: evidence for an involvement of nitric oxide.

Authors:  E Masini; D Bani; M G Bello; M Bigazzi; P F Mannaioni; T B Sacchi
Journal:  Endocrinology       Date:  1997-11       Impact factor: 4.736

3.  Relaxin protects against myocardial injury caused by ischemia and reperfusion in rat heart.

Authors:  D Bani; E Masini; M G Bello; M Bigazzi; T B Sacchi
Journal:  Am J Pathol       Date:  1998-05       Impact factor: 4.307

4.  Paradoxical influence of calcium ions on the permeability of the cell membranes of the isolated rat heart.

Authors:  A N Zimmerman; W C Hülsmann
Journal:  Nature       Date:  1966-08-06       Impact factor: 49.962

Review 5.  Mast cells in allergy and host defense.

Authors:  M L Taylor; D D Metcalfe
Journal:  Allergy Asthma Proc       Date:  2001 May-Jun       Impact factor: 2.587

6.  Radioimmunoassay (RIA) of relaxin in sera of various species using an antiserum to porcine relaxin.

Authors:  E M O'Byrne; B G Steinetz
Journal:  Proc Soc Exp Biol Med       Date:  1976-06

7.  Relaxin-induced increased coronary flow through stimulation of nitric oxide production.

Authors:  T Bani-Sacchi; M Bigazzi; D Bani; P F Mannaioni; E Masini
Journal:  Br J Pharmacol       Date:  1995-09       Impact factor: 8.739

8.  Histamine-releasing properties of Polysorbate 80 in vitro and in vivo: correlation with its hypotensive action in the dog.

Authors:  E Masini; J Planchenault; F Pezziardi; P Gautier; J P Gagnol
Journal:  Agents Actions       Date:  1985-09

9.  Production of hydroxyl radicals and their disassociation from myocardial cell injury during calcium paradox.

Authors:  E Duncan; T Onodera; M Ashraf
Journal:  Free Radic Biol Med       Date:  1992       Impact factor: 7.376

10.  Metabolism of glyceryl trinitrate to nitric oxide by endothelial cells and smooth muscle cells and its induction by Escherichia coli lipopolysaccharide.

Authors:  D Salvemini; V Mollace; A Pistelli; E Anggard; J Vane
Journal:  Proc Natl Acad Sci U S A       Date:  1992-02-01       Impact factor: 11.205

View more
  9 in total

Review 1.  Cardiovascular effects of relaxin: from basic science to clinical therapy.

Authors:  Xiao-Jun Du; Ross A D Bathgate; Chrishan S Samuel; Anthony M Dart; Roger J Summers
Journal:  Nat Rev Cardiol       Date:  2009-11-24       Impact factor: 32.419

Review 2.  The actions of relaxin on the human cardiovascular system.

Authors:  Mohsin Sarwar; Xiao-Jun Du; Thomas B Dschietzig; Roger J Summers
Journal:  Br J Pharmacol       Date:  2016-07-11       Impact factor: 8.739

3.  Enhanced serelaxin signalling in co-cultures of human primary endothelial and smooth muscle cells.

Authors:  M Sarwar; C S Samuel; R A Bathgate; D R Stewart; R J Summers
Journal:  Br J Pharmacol       Date:  2016-01-15       Impact factor: 8.739

4.  Relaxin signals through a RXFP1-pERK-nNOS-NO-cGMP-dependent pathway to up-regulate matrix metalloproteinases: the additional involvement of iNOS.

Authors:  Bryna Suet Man Chow; Elaine Guo Yan Chew; Chongxin Zhao; Ross A D Bathgate; Tim D Hewitson; Chrishan S Samuel
Journal:  PLoS One       Date:  2012-08-22       Impact factor: 3.240

5.  Tissue-specific relaxin-2 is differentially associated with the presence/size of an arterial aneurysm and the severity of atherosclerotic disease in humans.

Authors:  Konstantinos Papoutsis; Alkistis Kapelouzou; Georgios Georgiopoulos; Christos Kontogiannis; Christos Kourek; Konstantinos S Mylonas; Nikolaos Patelis; Dennis V Cokkinos; Ioannis Karavokyros; Sotirios Georgopoulos
Journal:  Acta Pharmacol Sin       Date:  2020-02-05       Impact factor: 6.150

Review 6.  Effect of Nitric Oxide Pathway Inhibition on the Evolution of Anaphylactic Shock in Animal Models: A Systematic Review.

Authors:  Maryam Alfalasi; Sarah Alzaabi; Linda Östlundh; Rami H Al-Rifai; Suhail Al-Salam; Paul Michel Mertes; Seth L Alper; Elhadi H Aburawi; Abdelouahab Bellou
Journal:  Biology (Basel)       Date:  2022-06-16

Review 7.  Cardiac anaphylaxis: pathophysiology and therapeutic perspectives.

Authors:  Daniele Bani; Silvia Nistri; Pier Francesco Mannaioni; Emanuela Masini
Journal:  Curr Allergy Asthma Rep       Date:  2006-02       Impact factor: 4.919

8.  Relaxin protects rat lungs from ischemia-reperfusion injury via inducible NO synthase: role of ERK-1/2, PI3K, and forkhead transcription factor FKHRL1.

Authors:  Konstantin Alexiou; Manuel Wilbring; Klaus Matschke; Thomas Dschietzig
Journal:  PLoS One       Date:  2013-09-30       Impact factor: 3.240

9.  Glucagon effects on 3H-histamine uptake by the isolated guinea-pig heart during anaphylaxis.

Authors:  Mirko Rosic; Oberdan Parodi; Vladimir Jakovljevic; Maja Colic; Vladimir Zivkovic; Vuk Jokovic; Suzana Pantovic
Journal:  Biomed Res Int       Date:  2014-05-11       Impact factor: 3.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.